News

Why not take a trip to Brighton to network with some spin-out agents? We'll be there.

Acrongenomics Inc., a Swiss life science venture company and Molecular Vision Ltd., a spin-out from the Imperial College London, said they have signed a memorandum of understanding to jointly develop diagnostic devices for diabetes, drug abuse, STDs and cardiovascular diseases.

In a funk after years of stagnation and high unemployment, Germany is looking to an unlikely alliance between football and R&D to kick start the economy.

An Israeli academic has developed a virtual reality device to help people with neurodegenerative diseases to improve their walking. He is now seeking funding of about $500,000 to commercialise it and looking for manufacturing partner.

How do you take a pill before you wake up? Denmark's Egalet has found an answer, and is looking for partners to help develop it.

A Linköpings Tekniska Högskola spin-out has developed plug-in devices for the direct production of 3D animations. The company is now looking for a first private funding round.

A new wave of companies with rich backers plans to change how people interact over the Internet. But sceptics are still searching for a sustainable business model.

Sweden is ranked number one among 31 European nations for its spending on R&D - but it is still looking for its first home-grown biotechnology product.

Philippe Pouletty is on a roll. One by one, the serial entrepreneur with a penchant for provocative lobbying is seeing his ideas become official French policy. But not everyone is pleased.

A small UK charity has turned entrepreneur to develop a low cost, mass manufactured, modern device to pump the blood of people whose heart muscle is failing.